MAP2K7 and breast cancer: We treated murine breast cancer cells with Pioglitazone alone and in combination with various clinically available MEK inhibitors, including Cobimetinib, Binimetinib, Selumetinib, and Trametinib, at different dose levels to evaluate their effectiveness in inducing adipogenesis.